Search
The COAG commitment to invest in young Aboriginal children will produce immediate and real community benefits.
The head of Indigenous research at Perth's The Kids for Child Health Research has been honoured as the 2008 National NAIDOC Person of the Year.
The Western Australian Aboriginal Child Health Survey is the most extensive survey of Aboriginal families ever undertaken.
A national strategy that focuses on early child development is the key to breaking the cycle of Aboriginal poor health and disadvantage.
Aboriginal children are faced with significant impediments to their chances of a healthy life even before they are born.
The impact of death, separation and divorce is having a profound impact on the lives of Aboriginal children.
High rates of recurrent infection are a major risk to the health of Aboriginal children and are comparable to those of third world countries.
This article considers the role of governance in Indigenous medical education research through the lens of an Australian Aboriginal research project titled Healing Conversations. The Healing Conversations project is developing and testing a targeted educational framework for improved clinical communication between healthcare practitioners and Australian Aboriginal peoples in regional and urban locations. It is proposed that an effective governance approach can support Indigenous and non-Indigenous stakeholders to work together in decision-making structures to enable outcomes that promote and prioritise Indigenous worldviews and values in medical education research.
The emerging literature on desistance (and recovery from addictions) has focused on key life-course transitions that can be characterised as the need for jobs (meaningful activities), friends (transitioning to pro-social) and houses (a home free from threat). The term ‘recovery capital’ is used to characterise personal, social and community resources an individual can draw upon to support their recovery, partly bridging agentic (personal) and structural (community) factors.
The Australasian guidelines recommend use of the CHA2 DS2 -VA schema to stratify ischaemic stroke risk in patients with non-valvular atrial fibrillation (N-VAF) and determine risk thresholds for recommending oral anticoagulant (OAC) therapy. However, the CHA2 DS2 -VA score has not been validated in a representative Australian population cohort with N-VAF, including in Aboriginal people who are known to have a higher age-adjusted stroke risk than other Australians.